MILAN, June 15, 2026 /PRNewswire/ — Addressing a critical technical limitation in multi-cycle imaging – the reliable adhesion and retention of suspension-derived, non-adherent cells – Tethis S.p.A. today announces the release of an application note for multiplex immunofluorescence…

Read the full release →

News provided by PR Newswire.